Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice.

Damiani, Giovanni; Manganoni, Ausilia; Cazzaniga, Simone; Naldi, Luigi (2018). Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice. (In Press). Giornale italiano di dermatologia e venereologia Minerva Medica 10.23736/S0392-0488.18.06033-9

Full text not available from this repository. (Request a copy)

BACKGROUND Target-therapy offers a better efficacy for several cancers, with less toxic adverse effects, if compared with traditional chemotherapy. However cutaneous complications are increased in number and complexity. The severity of these reactions positively correlates with efficacy, and the management of these reactions is challenging. METHODS This was a multicenter cross-sectional study on a consecutive series of adult patients with incident cutaneous reactions linked to targeted cancer therapies observed in five referral centers for cancer treatment in the province of Bergamo and Brescia in northern Italy. Each center was asked to collect data on the first 5 consecutive cases of severe adverse cutaneous events observed during a one-week surveillance period. RESULTS From June to October 2012, 25 patients with cutaneous adverse reactions linked to targeted therapies were included in the study. The main prescribed drugs were cetuximab (52%) and erlotinib (20%) and the most common reactions were folliculitis/pustules (40%) and rash/erythema (40%). Hand-foot reaction syndrome was present in 8% of patients. A total of 30% of patients treated for a cutaneous reaction underwent a consultation by a dermatologist. In these patients the rate of oncologic therapy continuation without regimen modifications was higher (100%), while it was progressively lower in patients treated by oncologists (71%) or without any specific treatment (60%). CONCLUSIONS Adverse reaction should be recognized by both dermatologists and oncologists and a multidisciplinary approach is mandatory.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Cazzaniga, Simone

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0026-4741

Publisher:

Minerva Medica

Language:

English

Submitter:

Sandra Nyffenegger

Date Deposited:

12 Feb 2019 14:21

Last Modified:

12 Feb 2019 14:21

Publisher DOI:

10.23736/S0392-0488.18.06033-9

PubMed ID:

29756421

URI:

https://boris.unibe.ch/id/eprint/123395

Actions (login required)

Edit item Edit item
Provide Feedback